Genetic testing continues to show an increased impact and improvement of human healthcare. This article outlines the ability to detect
Blog
Partnership Will Advance Putting Genome Sequenced Research Data On Blockchain Platform
Murrieta Genomics, the genomic sequencing business incubator, has agreed to
An article in Science magazine on December 13 explains how genomic sequencing was able to track the latest E. coli
In a recent post to the American Council on Science and Health, Alex Berezow examines a paper that declares current
Press Releases
“The simplSEQ workflow offers many workflow advantages over other methods of cell-free DNA extraction especially speed, simplicity, reproducibility, which are
Company Filed Second Patent Application to Extend Core Technology Applications
Murrieta Genomics is pleased to announce that U.S. Patent and Trademark
Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an incubator company and subsidiary,
“Our first product is a kit for the purification and isolation of nucleic acids from plasma that we believe will
Blog
Genetic testing continues to show an increased impact and improvement of human healthcare. This article outlines the ability to detect
Partnership Will Advance Putting Genome Sequenced Research Data On Blockchain Platform
Murrieta Genomics, the genomic sequencing business incubator, has agreed to
An article in Science magazine on December 13 explains how genomic sequencing was able to track the latest E. coli
In a recent post to the American Council on Science and Health, Alex Berezow examines a paper that declares current
Press Releases
“The simplSEQ workflow offers many workflow advantages over other methods of cell-free DNA extraction especially speed, simplicity, reproducibility, which are
Company Filed Second Patent Application to Extend Core Technology Applications
Murrieta Genomics is pleased to announce that U.S. Patent and Trademark
Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an incubator company and subsidiary,
“Our first product is a kit for the purification and isolation of nucleic acids from plasma that we believe will